Cite
MLA Citation
Jason Chesney et al.. “Phase IIIb safety results from an expanded-access protocol of talimogene laherparepvec for patients with unresected, stage IIIB–IVM1c melanoma.” Melanoma research, vol. 28, no. 1, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100074779597.0x000027